We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

83 hedge funds and large institutions have $222M invested in VanEck Biotech ETF in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 30 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

266% more call options, than puts

Call options by funds: $6.67M | Put options by funds: $1.82M

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

19.5% more ownership

Funds ownership: 33.2% → 52.71% (+20%)

5% more funds holding

Funds holding: 79 → 83 (+4)

5% more capital invested

Capital invested by funds: $211M → $222M (+$10.6M)

33% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 30

Holders
83
Holders Change
+4
Holders Change %
+5.06%
% of All Funds
2.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
20
Reduced
30
Closed
7
Calls
$6.67M
Puts
$1.82M
Net Calls
+$4.85M
Net Calls Change
+$2.12M

Top Buyers

Rank Fund Capital Flow
1
ZIM
Zacks Investment Management
Illinois
+$134M
2
AllianceBernstein
AllianceBernstein
Tennessee
+$16.4M
3
ECM
Endurant Capital Management
California
+$3.32M
4
AL
Aspiriant LLC
California
+$2.35M
5
Morgan Stanley
Morgan Stanley
New York
+$1.31M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$6.94M
2
VF
Virtu Financial
New York
-$6.06M
3
MLL
Moody Lynn & Lieberson
Massachusetts
-$4.65M
4
TRCT
Tower Research Capital (TRC)
New York
-$3.47M
5
BPC
Banque Pictet & Cie
Switzerland
-$1.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
ClearBridge Investments
26
ClearBridge Investments
New York
$883K -$6.03K -50 -0.7%
RJA
27
Raymond James & Associates
Florida
$798K +$48.2K +400 +7%
TBA
28
Train Babcock Advisors
New York
$782K -$382K -3,165 -34%
GJIC
29
Gamble Jones Investment Counsel
California
$754K – – –
Bank of New York Mellon
30
Bank of New York Mellon
New York
$691K -$3.5K -29 -0.5%
Wells Fargo
31
Wells Fargo
California
$690K -$145K -1,202 -18%
WJA
32
Williams Jones & Associates
New York
$688K -$72.3K -600 -10%
LTFS
33
Ladenburg Thalmann Financial Services
Florida
$568K +$165K +1,366 +43%
CAN
34
Cetera Advisor Networks
California
$542K +$63.1K +523 +14%
SBH
35
Segall Bryant & Hamill
Illinois
$540K +$127K +1,050 +32%
RJFSA
36
Raymond James Financial Services Advisors
Florida
$491K +$77.5K +643 +20%
Capital Fund Management (CFM)
37
Capital Fund Management (CFM)
France
$477K +$458K +3,800 New
IA
38
IFP Advisors
Florida
$476K +$5.43K +45 +1%
BPC
39
Banque Pictet & Cie
Switzerland
$471K -$1.45M -12,000 -76%
IAMOG
40
Investors Asset Management of Georgia
Georgia
$465K – – –
VWA
41
V Wealth Advisors
Kansas
$422K -$4.22K -35 -1%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$390K -$1.2M -9,960 -76%
SC
43
Scotia Capital
Ontario, Canada
$384K -$53.1K -440 -13%
First Manhattan
44
First Manhattan
New York
$376K – – –
MML Investors Services
45
MML Investors Services
Massachusetts
$368K +$353K +2,931 New
MJRIC
46
Mogy Joel R Investment Counsel
California
$361K +$83.8K +695 +32%
AB
47
Atlas Brown
Kentucky
$349K -$1.45K -12 -0.4%
TCM
48
Tufton Capital Management
Maryland
$333K – – –
Jane Street
49
Jane Street
New York
$281K -$830K -6,880 -75%
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$271K +$6.51K +54 +3%
1
2
3 4

BBH Hedge Fund Activity: Q2 2017 in Review

83 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2017, worth a combined $222M — up 5% from $211M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BBH positions and 7 closed out — a net gain of 4 holders — while 20 added to existing stakes and 30 trimmed.

The largest buyer was Zacks Investment Management, opening a new position worth an estimated $134M. The largest seller was Goldman Sachs, cutting an estimated $6.94M.

  • 83 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2017, up from 79 in Q1 2017.
  • Funds reported $222M of VanEck Biotech ETF stock for Q2 2017, up 5% quarter-over-quarter.
  • 11 funds opened new VanEck Biotech ETF positions in Q2 2017 and 7 closed out, a net change of +4 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2017 was Zacks Investment Management, an estimated $134M added.
  • The largest VanEck Biotech ETF seller in Q2 2017 was Goldman Sachs, an estimated $6.94M sold.

Based on aggregated 13F filings for Q2 2017.